Statistics about Health, Pharma & Medtech in United States
Statistics
- U.S. medical marijuana retail sales 2022-2028
- Zolpidem prescriptions in the U.S. 2013-2021
- Personalized medicines as percent of new molecular entities 2014-2023
- Share of newly FDA approved personalized medicines in 2023, by indicated treatment
- Number of e-prescriptions in the United States 2013-2023
- Number of e-prescriptions for controlled substances in the United States 2013-2023
- OTC sales volume of acne products and medicines in the U.S. 2020-2023
- Number of approved ANDAs in U.S. FY 2009-2023
- Federal drug control spending in the U.S. in FY 2025 by function
- Patients prescribed eszopiclone in the U.S. 2013-2020
- Patients prescribed zolpidem in the U.S. 2013-2021
- Total federal drug control spending in the U.S. 2012-2025
- OTC sales volume of suncare products in the U.S. 2011-2023
- Share of U.S. brand drugs meeting patent challenge before generic entry 1995-2014
- Share of older U.S. adults who would ask a health provider about marijuana 2017
- Leading U.S. states by synthetic pain medication overdose death rate 2016
- Opioid prescription regimen for short term medical conditions U.S. 2015
- High availability of controlled Rx drugs in U.S. 2010 and 2017, by region
- U.S. average invoice price increase for oncology brands 2012-2017
- U.S. medical cannabis patient perceptions of cannabis benefits 2017
- OTC revenue of acne products and medicines in the U.S. 2017-2023
- Percentage change in U.S. treatment price for cardiovascular disease from 2005-2015
- Doxepin prescriptions in the U.S. 2013-2020
- Share of zolpidem prescriptions in the U.S. 2021, by days supplied
- Leading traditional therapy areas in the U.S. by MAPD spending PMPY 2016
- Zolpidem average cost per prescription fill in the U.S. 2013-2021
- OTC sales volume of toothpaste in the U.S. 2011-2023
- Death rate from opioid overdose in the U.S. in 2022, by race/ethnicity
- Federal drug control spending share in the U.S. in FY 2025 by function
- Melatonin prescriptions in the U.S. 2013-2021
- Antibiotic treatment avoidance among U.S. adults with bronchitis 2008-2012, by region
- Past year nonmedical use of pain relievers by race/ethnicity in the U.S. 2017-2022
- U.S. legal medical marijuana patients 2023, by state
- Share of U.S. population who were medical marijuana patients 2023 by state
- Number of novel drugs approved annually by CDER 2008-2023
- Prescription opioid dispensing rates in the U.S. 2006-2022
- Average monthly Medicare Part B premium U.S. 2002-2022
- Prescription opioid overdose U.S. death rate 1999-2022
- Revenue in the pharmaceuticals market United States 2018-2029
- Oregon marijuana prices per ounce by quality and city 2023
- Revenue in the Pharmaceuticals market United States 2018-2029
- Top psychiatric drugs in the United States by sales 2016
- Top therapy areas in the U.S. by number of prescriptions 2022
- Total U.S. cannabidiol (CBD) industry sales by type 2016
- Number of Medicare plans offering drug coverage 2007-2024, by plan type
- Average monthly Medicare Part D (prescription drug plan) premium U.S. 2006-2024
- Number of Medicare PDP plans available in the U.S. 2023-2024, by state
- Colorado marijuana prices per ounce by quality and city 2023
- Annual brand name Rx drug price change for drugs among older Americans 2006-2020
- Colorado current active medical marijuana patients 2017-2022 by month
- Number of all FDA drug product recall enforcement reports issued 2012-2023
- Colorado current marijuana patients by condition 2022
- Support for medical marijuana legalization by cancer experience 2020
- Federal drug control treatment spending by HHS in FY 2024 by agency
- Drug control spending on treatment and prevention in the U.S. 2008-2025
- Top Medicaid prescriptions in 2019, by number of claims
- Top 10 Medicaid prescriptions by spending 2019
- Medicare Part B premium annual percentage change in the U.S. 2003-2022
- Annual retail price for widely used branded Rx rugs among older Americans 2006-2020
- Oregon registered medical marijuana patients, caregivers, growers and grow sites 2024
- Oregon registered medical marijuana patients by age 2024
- Oregon registered medical marijuana patients by condition 2024
- Oregon registered medical marijuana patients, caregivers, growers, by gender 2024
- Oregon medical marijuana patient reduced application fee eligibility 2012-2024
- Support/oppose increased funding for research on opioid addiction U.S. 2024
- Number of cannabis dispensary licenses in the U.S. 2021, by state
- U.S. children and adults who spent on complementary health approaches by type 2012
- Opinions on prescription opioid use among cancer patients U.S. 2018, by age
- U.S. spending on therapeutic oncology and supportive care by type 2011-2015
- OTC revenue of heartburn products in the U.S. 2017-2023
- OTC revenue of foot care in the U.S. 2017-2023
- Number of opioid prescriptions U.S. 2006-2022
- Support for U.S. marijuana legalization 2000-2023, by age
- Support for U.S. marijuana legalization 2000-2023, by political affiliation
- Support for U.S. marijuana legalization 1969-2023
- OTC revenue of hair growth products in the U.S. 2011-2023
- OTC revenue of homeopathic remedies in the U.S. 2011-2017
- OTC revenue from feminine itch and yeast treatment in the U.S. 2017-2023
- OTC revenue of jock itch products in the U.S. 2011-2023
- OTC revenue of laxatives in the U.S. 2017-2023
- Adults that did not take medication as prescribed to lower drug costs by age 2013
- OTC revenue of lip remedies in the U.S. 2011-2023
- OTC revenue of motion sickness products in the U.S. 2011-2023
- Eszopiclone prescriptions in the U.S. 2013-2020
- Share of doxepin prescriptions in the U.S. 2020, by days supplied
- Health app ownership distribution in the U.S. 2020-2021, by gender
- OTC revenue of female contraceptive in the U.S. 2011-2023
- Direct-to-consumer advertising spending for Eliquis U.S. 2013-2018
- OTC revenue of antidiarrheals in the U.S. 2011-2023
- Share of U.S. adults not taking medicine as prescribed to reduce costs 2021, by age
- Share of U.S. adults not taking medicine as prescribed to reduce costs 2021 by gender
- U.S. adults not taking medicine as prescribed 2021, by insurance status
- Market share of orphan drugs valued >$6,000 per year 2017, by therapy class
- Flow of payments for 3,000 USD HIV medication with patient coinsurance U.S. 2017
- OTC total sales volume in the U.S. 2017-2023
- OTC revenue of internal analgesics in the U.S. 2017-2023
- OTC revenue of eye care in the U.S. 2017-2023
- OTC revenue of external analgesics in the U.S. 2017-2023
- OTC revenue of antiperspirants in the U.S. 2017-2023
- OTC revenue of diuretic products in the U.S. 2011-2017